0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Volume Parenterals (SVP) Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-2L9865
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Small Volume Parenterals SVP Market Insights and Forecast to 2028
BUY CHAPTERS

Global Small Volume Parenterals (SVP) Market Insights, Forecast to 2030

Code: QYRE-Auto-2L9865
Report
December 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Small Volume Parenterals (SVP) Market

Small volume parenteral (SVP) solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.
The global Small Volume Parenterals (SVP) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Small Volume Parenterals (SVP) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Small Volume Parenterals (SVP) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Small Volume Parenterals (SVP) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Small Volume Parenterals (SVP) include Allergan, Bayer, GSK, J&J, Pfizer, Teva and Novartis, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Small Volume Parenterals (SVP), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Small Volume Parenterals (SVP), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Small Volume Parenterals (SVP), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Small Volume Parenterals (SVP) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Small Volume Parenterals (SVP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Small Volume Parenterals (SVP) sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Small Volume Parenterals (SVP) Market Report

Report Metric Details
Report Name Small Volume Parenterals (SVP) Market
Segment by Type
  • Ampules
  • Vials
  • Prefilled Syringes
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, J&J, Pfizer, Teva, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Small Volume Parenterals (SVP) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Small Volume Parenterals (SVP) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Volume Parenterals (SVP) sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Small Volume Parenterals (SVP) Market report?

Ans: The main players in the Small Volume Parenterals (SVP) Market are GSK, J&J, Pfizer, Teva, Novartis

What are the Application segmentation covered in the Small Volume Parenterals (SVP) Market report?

Ans: The Applications covered in the Small Volume Parenterals (SVP) Market report are Local Anesthetics, Vaccines, Other

What are the Type segmentation covered in the Small Volume Parenterals (SVP) Market report?

Ans: The Types covered in the Small Volume Parenterals (SVP) Market report are Ampules, Vials, Prefilled Syringes

Recommended Reports

Parenteral Products

Packaging & Containers

Syringes & Delivery

1 Study Coverage
1.1 Small Volume Parenterals (SVP) Product Introduction
1.2 Market by Type
1.2.1 Global Small Volume Parenterals (SVP) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ampules
1.2.3 Vials
1.2.4 Prefilled Syringes
1.3 Market by Application
1.3.1 Global Small Volume Parenterals (SVP) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Local Anesthetics
1.3.3 Vaccines
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Small Volume Parenterals (SVP) Sales Estimates and Forecasts 2019-2030
2.2 Global Small Volume Parenterals (SVP) Revenue by Region
2.2.1 Global Small Volume Parenterals (SVP) Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Small Volume Parenterals (SVP) Revenue by Region (2019-2024)
2.2.3 Global Small Volume Parenterals (SVP) Revenue by Region (2025-2030)
2.2.4 Global Small Volume Parenterals (SVP) Revenue Market Share by Region (2019-2030)
2.3 Global Small Volume Parenterals (SVP) Sales Estimates and Forecasts 2019-2030
2.4 Global Small Volume Parenterals (SVP) Sales by Region
2.4.1 Global Small Volume Parenterals (SVP) Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Small Volume Parenterals (SVP) Sales by Region (2019-2024)
2.4.3 Global Small Volume Parenterals (SVP) Sales by Region (2025-2030)
2.4.4 Global Small Volume Parenterals (SVP) Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Small Volume Parenterals (SVP) Sales by Manufacturers
3.1.1 Global Small Volume Parenterals (SVP) Sales by Manufacturers (2019-2024)
3.1.2 Global Small Volume Parenterals (SVP) Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Small Volume Parenterals (SVP) in 2023
3.2 Global Small Volume Parenterals (SVP) Revenue by Manufacturers
3.2.1 Global Small Volume Parenterals (SVP) Revenue by Manufacturers (2019-2024)
3.2.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Small Volume Parenterals (SVP) Revenue in 2023
3.3 Global Key Players of Small Volume Parenterals (SVP), Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Small Volume Parenterals (SVP) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Small Volume Parenterals (SVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Small Volume Parenterals (SVP), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Small Volume Parenterals (SVP), Product Offered and Application
3.8 Global Key Manufacturers of Small Volume Parenterals (SVP), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Small Volume Parenterals (SVP) Sales by Type
4.1.1 Global Small Volume Parenterals (SVP) Historical Sales by Type (2019-2024)
4.1.2 Global Small Volume Parenterals (SVP) Forecasted Sales by Type (2025-2030)
4.1.3 Global Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
4.2 Global Small Volume Parenterals (SVP) Revenue by Type
4.2.1 Global Small Volume Parenterals (SVP) Historical Revenue by Type (2019-2024)
4.2.2 Global Small Volume Parenterals (SVP) Forecasted Revenue by Type (2025-2030)
4.2.3 Global Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
4.3 Global Small Volume Parenterals (SVP) Price by Type
4.3.1 Global Small Volume Parenterals (SVP) Price by Type (2019-2024)
4.3.2 Global Small Volume Parenterals (SVP) Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Small Volume Parenterals (SVP) Sales by Application
5.1.1 Global Small Volume Parenterals (SVP) Historical Sales by Application (2019-2024)
5.1.2 Global Small Volume Parenterals (SVP) Forecasted Sales by Application (2025-2030)
5.1.3 Global Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
5.2 Global Small Volume Parenterals (SVP) Revenue by Application
5.2.1 Global Small Volume Parenterals (SVP) Historical Revenue by Application (2019-2024)
5.2.2 Global Small Volume Parenterals (SVP) Forecasted Revenue by Application (2025-2030)
5.2.3 Global Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
5.3 Global Small Volume Parenterals (SVP) Price by Application
5.3.1 Global Small Volume Parenterals (SVP) Price by Application (2019-2024)
5.3.2 Global Small Volume Parenterals (SVP) Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Small Volume Parenterals (SVP) Market Size by Type
6.1.1 US & Canada Small Volume Parenterals (SVP) Sales by Type (2019-2030)
6.1.2 US & Canada Small Volume Parenterals (SVP) Revenue by Type (2019-2030)
6.2 US & Canada Small Volume Parenterals (SVP) Market Size by Application
6.2.1 US & Canada Small Volume Parenterals (SVP) Sales by Application (2019-2030)
6.2.2 US & Canada Small Volume Parenterals (SVP) Revenue by Application (2019-2030)
6.3 US & Canada Small Volume Parenterals (SVP) Market Size by Country
6.3.1 US & Canada Small Volume Parenterals (SVP) Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Small Volume Parenterals (SVP) Sales by Country (2019-2030)
6.3.3 US & Canada Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Small Volume Parenterals (SVP) Market Size by Type
7.1.1 Europe Small Volume Parenterals (SVP) Sales by Type (2019-2030)
7.1.2 Europe Small Volume Parenterals (SVP) Revenue by Type (2019-2030)
7.2 Europe Small Volume Parenterals (SVP) Market Size by Application
7.2.1 Europe Small Volume Parenterals (SVP) Sales by Application (2019-2030)
7.2.2 Europe Small Volume Parenterals (SVP) Revenue by Application (2019-2030)
7.3 Europe Small Volume Parenterals (SVP) Market Size by Country
7.3.1 Europe Small Volume Parenterals (SVP) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Small Volume Parenterals (SVP) Sales by Country (2019-2030)
7.3.3 Europe Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Small Volume Parenterals (SVP) Market Size
8.1.1 China Small Volume Parenterals (SVP) Sales (2019-2030)
8.1.2 China Small Volume Parenterals (SVP) Revenue (2019-2030)
8.2 China Small Volume Parenterals (SVP) Market Size by Application
8.2.1 China Small Volume Parenterals (SVP) Sales by Application (2019-2030)
8.2.2 China Small Volume Parenterals (SVP) Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Small Volume Parenterals (SVP) Market Size by Type
9.1.1 Asia Small Volume Parenterals (SVP) Sales by Type (2019-2030)
9.1.2 Asia Small Volume Parenterals (SVP) Revenue by Type (2019-2030)
9.2 Asia Small Volume Parenterals (SVP) Market Size by Application
9.2.1 Asia Small Volume Parenterals (SVP) Sales by Application (2019-2030)
9.2.2 Asia Small Volume Parenterals (SVP) Revenue by Application (2019-2030)
9.3 Asia Small Volume Parenterals (SVP) Sales by Region
9.3.1 Asia Small Volume Parenterals (SVP) Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Small Volume Parenterals (SVP) Revenue by Region (2019-2030)
9.3.3 Asia Small Volume Parenterals (SVP) Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Market Size by Type
10.1.1 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Market Size by Application
10.2.1 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Country
10.3.1 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Overview
11.1.3 Allergan Small Volume Parenterals (SVP) Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Allergan Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Small Volume Parenterals (SVP) Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bayer Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Small Volume Parenterals (SVP) Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 GSK Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 J&J
11.4.1 J&J Company Information
11.4.2 J&J Overview
11.4.3 J&J Small Volume Parenterals (SVP) Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 J&J Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 J&J Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Small Volume Parenterals (SVP) Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Pfizer Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Overview
11.6.3 Teva Small Volume Parenterals (SVP) Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Teva Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Overview
11.7.3 Novartis Small Volume Parenterals (SVP) Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Novartis Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Small Volume Parenterals (SVP) Industry Chain Analysis
12.2 Small Volume Parenterals (SVP) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Small Volume Parenterals (SVP) Production Mode & Process
12.4 Small Volume Parenterals (SVP) Sales and Marketing
12.4.1 Small Volume Parenterals (SVP) Sales Channels
12.4.2 Small Volume Parenterals (SVP) Distributors
12.5 Small Volume Parenterals (SVP) Customers
13 Market Dynamics
13.1 Small Volume Parenterals (SVP) Industry Trends
13.2 Small Volume Parenterals (SVP) Market Drivers
13.3 Small Volume Parenterals (SVP) Market Challenges
13.4 Small Volume Parenterals (SVP) Market Restraints
14 Key Findings in The Global Small Volume Parenterals (SVP) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Small Volume Parenterals (SVP) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Ampules
    Table 3. Major Manufacturers of Vials
    Table 4. Major Manufacturers of Prefilled Syringes
    Table 5. Global Small Volume Parenterals (SVP) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Small Volume Parenterals (SVP) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Small Volume Parenterals (SVP) Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Small Volume Parenterals (SVP) Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Small Volume Parenterals (SVP) Revenue Market Share by Region (2019-2024)
    Table 10. Global Small Volume Parenterals (SVP) Revenue Market Share by Region (2025-2030)
    Table 11. Global Small Volume Parenterals (SVP) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Small Volume Parenterals (SVP) Sales by Region (2019-2024) & (K Doses)
    Table 13. Global Small Volume Parenterals (SVP) Sales by Region (2025-2030) & (K Doses)
    Table 14. Global Small Volume Parenterals (SVP) Sales Market Share by Region (2019-2024)
    Table 15. Global Small Volume Parenterals (SVP) Sales Market Share by Region (2025-2030)
    Table 16. Global Small Volume Parenterals (SVP) Sales by Manufacturers (2019-2024) & (K Doses)
    Table 17. Global Small Volume Parenterals (SVP) Sales Share by Manufacturers (2019-2024)
    Table 18. Global Small Volume Parenterals (SVP) Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Small Volume Parenterals (SVP) Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Small Volume Parenterals (SVP), Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Small Volume Parenterals (SVP) Price by Manufacturers 2019-2024 (USD/Dose)
    Table 22. Global Small Volume Parenterals (SVP) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Small Volume Parenterals (SVP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Volume Parenterals (SVP) as of 2023)
    Table 24. Global Key Manufacturers of Small Volume Parenterals (SVP), Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Small Volume Parenterals (SVP), Product Offered and Application
    Table 26. Global Key Manufacturers of Small Volume Parenterals (SVP), Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Small Volume Parenterals (SVP) Sales by Type (2019-2024) & (K Doses)
    Table 29. Global Small Volume Parenterals (SVP) Sales by Type (2025-2030) & (K Doses)
    Table 30. Global Small Volume Parenterals (SVP) Sales Share by Type (2019-2024)
    Table 31. Global Small Volume Parenterals (SVP) Sales Share by Type (2025-2030)
    Table 32. Global Small Volume Parenterals (SVP) Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Small Volume Parenterals (SVP) Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Small Volume Parenterals (SVP) Revenue Share by Type (2019-2024)
    Table 35. Global Small Volume Parenterals (SVP) Revenue Share by Type (2025-2030)
    Table 36. Small Volume Parenterals (SVP) Price by Type (2019-2024) & (USD/Dose)
    Table 37. Global Small Volume Parenterals (SVP) Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 38. Global Small Volume Parenterals (SVP) Sales by Application (2019-2024) & (K Doses)
    Table 39. Global Small Volume Parenterals (SVP) Sales by Application (2025-2030) & (K Doses)
    Table 40. Global Small Volume Parenterals (SVP) Sales Share by Application (2019-2024)
    Table 41. Global Small Volume Parenterals (SVP) Sales Share by Application (2025-2030)
    Table 42. Global Small Volume Parenterals (SVP) Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Small Volume Parenterals (SVP) Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Small Volume Parenterals (SVP) Revenue Share by Application (2019-2024)
    Table 45. Global Small Volume Parenterals (SVP) Revenue Share by Application (2025-2030)
    Table 46. Small Volume Parenterals (SVP) Price by Application (2019-2024) & (USD/Dose)
    Table 47. Global Small Volume Parenterals (SVP) Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 48. US & Canada Small Volume Parenterals (SVP) Sales by Type (2019-2024) & (K Doses)
    Table 49. US & Canada Small Volume Parenterals (SVP) Sales by Type (2025-2030) & (K Doses)
    Table 50. US & Canada Small Volume Parenterals (SVP) Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Small Volume Parenterals (SVP) Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Small Volume Parenterals (SVP) Sales by Application (2019-2024) & (K Doses)
    Table 53. US & Canada Small Volume Parenterals (SVP) Sales by Application (2025-2030) & (K Doses)
    Table 54. US & Canada Small Volume Parenterals (SVP) Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Small Volume Parenterals (SVP) Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Small Volume Parenterals (SVP) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Small Volume Parenterals (SVP) Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Small Volume Parenterals (SVP) Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Small Volume Parenterals (SVP) Sales by Country (2019-2024) & (K Doses)
    Table 60. US & Canada Small Volume Parenterals (SVP) Sales by Country (2025-2030) & (K Doses)
    Table 61. Europe Small Volume Parenterals (SVP) Sales by Type (2019-2024) & (K Doses)
    Table 62. Europe Small Volume Parenterals (SVP) Sales by Type (2025-2030) & (K Doses)
    Table 63. Europe Small Volume Parenterals (SVP) Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Small Volume Parenterals (SVP) Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Small Volume Parenterals (SVP) Sales by Application (2019-2024) & (K Doses)
    Table 66. Europe Small Volume Parenterals (SVP) Sales by Application (2025-2030) & (K Doses)
    Table 67. Europe Small Volume Parenterals (SVP) Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Small Volume Parenterals (SVP) Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Small Volume Parenterals (SVP) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Small Volume Parenterals (SVP) Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Small Volume Parenterals (SVP) Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Small Volume Parenterals (SVP) Sales by Country (2019-2024) & (K Doses)
    Table 73. Europe Small Volume Parenterals (SVP) Sales by Country (2025-2030) & (K Doses)
    Table 74. China Small Volume Parenterals (SVP) Sales by Type (2019-2024) & (K Doses)
    Table 75. China Small Volume Parenterals (SVP) Sales by Type (2025-2030) & (K Doses)
    Table 76. China Small Volume Parenterals (SVP) Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Small Volume Parenterals (SVP) Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Small Volume Parenterals (SVP) Sales by Application (2019-2024) & (K Doses)
    Table 79. China Small Volume Parenterals (SVP) Sales by Application (2025-2030) & (K Doses)
    Table 80. China Small Volume Parenterals (SVP) Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Small Volume Parenterals (SVP) Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Small Volume Parenterals (SVP) Sales by Type (2019-2024) & (K Doses)
    Table 83. Asia Small Volume Parenterals (SVP) Sales by Type (2025-2030) & (K Doses)
    Table 84. Asia Small Volume Parenterals (SVP) Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Small Volume Parenterals (SVP) Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Small Volume Parenterals (SVP) Sales by Application (2019-2024) & (K Doses)
    Table 87. Asia Small Volume Parenterals (SVP) Sales by Application (2025-2030) & (K Doses)
    Table 88. Asia Small Volume Parenterals (SVP) Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Small Volume Parenterals (SVP) Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Small Volume Parenterals (SVP) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Small Volume Parenterals (SVP) Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Small Volume Parenterals (SVP) Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Small Volume Parenterals (SVP) Sales by Region (2019-2024) & (K Doses)
    Table 94. Asia Small Volume Parenterals (SVP) Sales by Region (2025-2030) & (K Doses)
    Table 95. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Type (2019-2024) & (K Doses)
    Table 96. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Type (2025-2030) & (K Doses)
    Table 97. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Application (2019-2024) & (K Doses)
    Table 100. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Application (2025-2030) & (K Doses)
    Table 101. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Country (2019-2024) & (K Doses)
    Table 107. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales by Country (2025-2030) & (K Doses)
    Table 108. Allergan Company Information
    Table 109. Allergan Description and Major Businesses
    Table 110. Allergan Small Volume Parenterals (SVP) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 111. Allergan Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Allergan Recent Developments
    Table 113. Bayer Company Information
    Table 114. Bayer Description and Major Businesses
    Table 115. Bayer Small Volume Parenterals (SVP) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 116. Bayer Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bayer Recent Developments
    Table 118. GSK Company Information
    Table 119. GSK Description and Major Businesses
    Table 120. GSK Small Volume Parenterals (SVP) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 121. GSK Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. GSK Recent Developments
    Table 123. J&J Company Information
    Table 124. J&J Description and Major Businesses
    Table 125. J&J Small Volume Parenterals (SVP) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 126. J&J Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. J&J Recent Developments
    Table 128. Pfizer Company Information
    Table 129. Pfizer Description and Major Businesses
    Table 130. Pfizer Small Volume Parenterals (SVP) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 131. Pfizer Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Pfizer Recent Developments
    Table 133. Teva Company Information
    Table 134. Teva Description and Major Businesses
    Table 135. Teva Small Volume Parenterals (SVP) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 136. Teva Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Teva Recent Developments
    Table 138. Novartis Company Information
    Table 139. Novartis Description and Major Businesses
    Table 140. Novartis Small Volume Parenterals (SVP) Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 141. Novartis Small Volume Parenterals (SVP) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Novartis Recent Developments
    Table 143. Key Raw Materials Lists
    Table 144. Raw Materials Key Suppliers Lists
    Table 145. Small Volume Parenterals (SVP) Distributors List
    Table 146. Small Volume Parenterals (SVP) Customers List
    Table 147. Small Volume Parenterals (SVP) Market Trends
    Table 148. Small Volume Parenterals (SVP) Market Drivers
    Table 149. Small Volume Parenterals (SVP) Market Challenges
    Table 150. Small Volume Parenterals (SVP) Market Restraints
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Small Volume Parenterals (SVP) Product Picture
    Figure 2. Global Small Volume Parenterals (SVP) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Small Volume Parenterals (SVP) Market Share by Type in 2023 & 2030
    Figure 4. Ampules Product Picture
    Figure 5. Vials Product Picture
    Figure 6. Prefilled Syringes Product Picture
    Figure 7. Global Small Volume Parenterals (SVP) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Small Volume Parenterals (SVP) Market Share by Application in 2023 & 2030
    Figure 9. Local Anesthetics
    Figure 10. Vaccines
    Figure 11. Other
    Figure 12. Small Volume Parenterals (SVP) Report Years Considered
    Figure 13. Global Small Volume Parenterals (SVP) Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Small Volume Parenterals (SVP) Revenue 2019-2030 (US$ Million)
    Figure 15. Global Small Volume Parenterals (SVP) Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Small Volume Parenterals (SVP) Revenue Market Share by Region (2019-2030)
    Figure 17. Global Small Volume Parenterals (SVP) Sales 2019-2030 ((K Doses)
    Figure 18. Global Small Volume Parenterals (SVP) Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Small Volume Parenterals (SVP) Sales YoY (2019-2030) & (K Doses)
    Figure 20. US & Canada Small Volume Parenterals (SVP) Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Small Volume Parenterals (SVP) Sales YoY (2019-2030) & (K Doses)
    Figure 22. Europe Small Volume Parenterals (SVP) Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Small Volume Parenterals (SVP) Sales YoY (2019-2030) & (K Doses)
    Figure 24. China Small Volume Parenterals (SVP) Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Small Volume Parenterals (SVP) Sales YoY (2019-2030) & (K Doses)
    Figure 26. Asia (excluding China) Small Volume Parenterals (SVP) Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales YoY (2019-2030) & (K Doses)
    Figure 28. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Small Volume Parenterals (SVP) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Small Volume Parenterals (SVP) in the World: Market Share by Small Volume Parenterals (SVP) Revenue in 2023
    Figure 31. Global Small Volume Parenterals (SVP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
    Figure 33. Global Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
    Figure 34. Global Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
    Figure 35. Global Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Small Volume Parenterals (SVP) Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Small Volume Parenterals (SVP) Sales Share by Country (2019-2030)
    Figure 42. U.S. Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
    Figure 45. Europe Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
    Figure 47. Europe Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Small Volume Parenterals (SVP) Revenue Share by Country (2019-2030)
    Figure 49. Europe Small Volume Parenterals (SVP) Sales Share by Country (2019-2030)
    Figure 50. Germany Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 51. France Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 55. China Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
    Figure 56. China Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
    Figure 57. China Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
    Figure 58. China Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
    Figure 60. Asia Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
    Figure 62. Asia Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Small Volume Parenterals (SVP) Revenue Share by Region (2019-2030)
    Figure 64. Asia Small Volume Parenterals (SVP) Sales Share by Region (2019-2030)
    Figure 65. Japan Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 69. India Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Small Volume Parenterals (SVP) Sales Share by Country (2019-2030)
    Figure 76. Brazil Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Small Volume Parenterals (SVP) Revenue (2019-2030) & (US$ Million)
    Figure 81. Small Volume Parenterals (SVP) Value Chain
    Figure 82. Small Volume Parenterals (SVP) Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc